CCL2 and diabetes mellitus: In this study, we assessed the expression levels of CDH1, CDH2, MCP-1, and PAI-1 mRNAs in blood EVs of overt DN, incipient DN, and DM patients compared to healthy controls and investigated whether or not these mRNAs could serve as diagnostic biomarkers for early-stage DN.